Down-regulation of cyclin D1 expression by prostaglandin A2 is mediated by enhanced cyclin D1 mRNA turnover

Molecular and Cellular Biology

Volumn 20, Issue 21, 2000, Pages 7903-7913

  Lin, S ^a   Wang, W ^a   Wilson, G M ^a   Yang, X ^a   Brewer, G ^a   Holbrook, N J ^a   Gorospe, M ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; ANTINEOPLASTIC AGENT; CYCLIN D1; LUCIFERASE; MESSENGER RNA; PROSTAGLANDIN A2; PROTEIN AUF1; RNA BINDING PROTEIN; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ARTICLE; CANCER; CONTROLLED STUDY; DOWN REGULATION; ELECTROPHORETIC MOBILITY; GENE EXPRESSION REGULATION; GENE INSERTION; GENETIC TRANSCRIPTION; GROWTH INHIBITION; HUMAN; HUMAN CELL; LUNG NON SMALL CELL CANCER; MOLECULAR STABILITY; PRIORITY JOURNAL; PROTEIN RNA BINDING; RNA DEGRADATION; RNA METABOLISM; RNA PROBE;

3' UNTRANSLATED REGIONS; BLOTTING, NORTHERN; BLOTTING, WESTERN; CELL DIVISION; CELL NUCLEUS; CROSS-LINKING REAGENTS; CYCLIN D1; CYTOPLASM; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; GENES, REPORTER; HUMAN; KINETICS; MODELS, GENETIC; PRECIPITIN TESTS; PROMOTER REGIONS (GENETICS); PROSTAGLANDINS A; PROTEIN BINDING; RNA; RNA, MESSENGER; RNA-BINDING PROTEINS; SUBCELLULAR FRACTIONS; SUPPORT, U.S. GOV'T, P.H.S.; TIME FACTORS; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION, GENETIC; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0033773041     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.20.21.7903-7913.2000     Document Type: Article

References (64)

1. Transforming p21(ras) mutants and c-Ets-2 activate the cyclin D1 promoter through distinguishable regions
2. Induction of thermotolerance by prostaglandin A in human cells
3. Regulated mRNA stability
4. Cyclin D1 is a nuclear protein required for cell cycle progression in G1
5. Identification of the cyclin D1 gene as a target of activating transcription factor 2 in chrondrocytes
6. An A + U-rich element RNA binding factor regulates c-myc mRNA stability in vitro
7. Increased GM-CSF mRNA stability in cord vs. adult mononuclear cells is translation dependent and associated with increased levels of A+U-rich element binding factor
8. Identification of a common nucleotide sequence in the 3'-untranslated region of mRNA molecules specifying inflammatory mediators
9. AU-rich elements: Characterization and importance in mRNA degradation
10. Purification and properties of HuD, a neuronal RNA-binding protein
11. AUF1 binding affinity to A+U-rich elements correlates with rapid mRNA degradation
12. Structural determinants in AUF1 required for high affinity binding to A + U-rich elements
13. Amplification of chromosome band 11q13 and a role for cyclin D1 in human breast cancer
14. Overexpression of HuR, a nuclear-cytoplasmic shuttling protein, increases the in vivo stability of ARE-containing mRNAs
15. ELAV proteins stabilize deadenylated intermediates in a novel in vitro mRNA deadenylation/degradation system
16. Prostaglandin J2 and related compounds: Mode of action in G1 arrest and preclinical results
17. + mRNA in granular RNP structures and are implicated in neuronal differentiation
18. Tumor necrosis factor increases the stability of interleukin-1 mRNA by activating protein kinase C
19. Degradation of unstable interleukin-1 alpha mRNA in a rabbit reticulocyte cell-free system. Localization of the instability determinant to a cluster of AUUUA motifs
20. 2
21. p53-Dependent elevation of p21(Waf1) expression by UV light is mediated through mRNA stabilization and involves a vanadate-sensitive regulatory system
22. Cell cycle control in mammalian cells: Role of cyclins, cyclin dependent kinases (CDKs), growth suppressor genes and cyclin-dependent kinase inhibitors (CKIs)
23. Rapamycin inhibition of the G1 to S transition is mediated by effects on cyclin D1 mRNA and protein stability
24. 2: A growth-dependent response mediated by activation of heat shock transcription factor
25. Mechanism of cyclin D1 (CCND1, PRAD1) overexpression in human cancer cells: Analysis of allele-specific expression
26. A small deletion in the 3'-untranslated region of the cyclin D1/PRAD1/bcl-1 oncogene in a patient with chronic lymphocytic leukemia
27. 1 at the G1/S phase interface with up-regulation of oncogenes in S-49 cyc- cells
28. Adjuvant effects of antineoplastic prostaglandins to cisplatin in nude mice bearing human ovarian cancer cells
29. Modulation of human lymphocyte response to phytohemagglutinin by antineoplastic prostaglandins
30. AUUUA is not sufficient to promote poly(A) shortening and degradation of an mRNA: The functional sequence within AU-rich elements may be UUAUUUA(U/A) (U/A)
31. Posttranslational regulation of cyclin D1 by retinoic acid: A chemoprevention mechanism
32. Cyclin D1 expression is regulated positively by the p42/p44(MAPK) and negatively by p38/HOG(MAPK) pathway
33. A truncated cyclin D1 gene encodes a stable mRNA in a human breast cancer cell line
34. mRNA stability and the control of gene expression
35. Unraveling a cytoplasmic role for hnRNP D in the in vivo mRNA destabilization directed by the AU-rich element
36. Transcriptional regulation of the cyclin D1 promoter by STAT5: Its involvement in cytokine-dependent growth of hematopoietic cells
37. Cell cycle control in normal and neoplastic cells
38. Cyclin D1 expression is controlled post-transcriptionally via a phosphatidylinositol 3-kinase/Akt-dependent pathway
39. Cyclin D1 expression is regulated by the retinoblastoma protein
40. Cyclin D1 induction in breast cancer cells shortens G1 and is sufficient for cells arrested in G1 to complete the cell cycle
41. Cyclin D1 overexpression in malignant lymphomas
42. 2-induced growth inhibition
43. Cyclin-dependent regulation of G1 in mammalian cells
44. RNA stabilization by the AU-rich element binding protein, HuR, an ELAV protein
45. Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts
46. 1/S phase transition by expression of cyclins D1 and E with an inducible system
47. Rearrangement of CCND1 (BCL1/PRAD1) 3' untranslated region in mantle-cell lymphomas and t(11q13)-associated leukemias
48. mRNA stability in mammalian cells
49. A hypothesis to explain why translation inhibitors stabilize mRNAs in mammalian cells: mRNA stability and mitosis
50. Messenger RNA degradation in eukaryotes
51. Prostaglandins in the treatment of cancer
52. 2
53. A conserved AU sequence from the 3' untranslated region of GM-CSF mRNA mediates selective mRNA degradation
54. Mammalian G1 cyclins
55. Structure and genomic organization of the human AUF1 gene: Alternative pre-mRNA splicing generates four protein isoforms
56. Inhibition of cell proliferation in head and neck squamous cell carcinoma cell lines with antisense cyclin D1
57. Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice
58. HuR regulates p21 mRNA stabilization by UV light
59. HuR regulates cyclin A and cyclin B1 mRNA stability during the cell division cycle
60. The retinoblastoma protein and cell cycle control
61. Identification and characterization of proteins binding A + U-rich elements
62. Regulation of AUF1 expression via conserved alternatively spliced elements in the 3' untranslated region
63. A broader role for AU-rich element-mediated mRNA turnover revealed by a new transcriptional pulse strategy
64. Purification, characterization, and cDNA cloning of an AU-rich element RNA-binding protein, AUF1